(Q33804473)

29 July 2017

1 reference

title

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management (English)

1 reference

Anticonvulsant hypersensitivity syndrome

29 July 2017

1 reference

S R Knowles

1

1 reference

29 July 2017

L E Shapiro

series ordinal

2

1 reference

29 July 2017

N H Shear

series ordinal

3

1 reference

29 July 2017

language of work or name

1 reference

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

21

1 reference

29 July 2017

489-501

1 reference

29 July 2017

6

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199921060-00005

29 July 2017

0 references

cites work

Phenytoin-carbamazepine cross-sensitivity

1 reference

12 December 2020

Fatal course of toxic epidermal necrolysis under treatment with lamotrigine

1 reference

12 December 2020

Carbamazepine-induced severe systemic hypersensitivity reaction with eosinophilia

1 reference

12 December 2020

Cross sensitivity of skin rashes with antiepileptic drugs

1 reference

12 December 2020

Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity

1 reference

12 December 2020

Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases

1 reference

12 December 2020

Mechanisms of drug reactions: the metabolic track

1 reference

12 December 2020

Studies on the mechanism of drug sensitization: T-cell-dependent popliteal lymph node reaction to diphenylhydantoin

1 reference

12 December 2020

The anticonvulsant hypersensitivity syndrome

1 reference

12 December 2020

Mycosis fungoides-like lesions associated with phenytoin therapy.

1 reference

12 December 2020

Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity

1 reference

12 December 2020

Phenytoin hepatotoxicity: a case report and review

1 reference

12 December 2020

Quantifying the costs of serious adverse drug reactions to antiepileptic drugs

1 reference

12 December 2020

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

12 December 2020

[Drug hypersensitivity syndrome during treatment with valproic acid]

1 reference

12 December 2020

Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis

1 reference

12 December 2020

Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.

1 reference

12 December 2020

Multisystem adverse reaction to lamotrigine

1 reference

12 December 2020

Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management

1 reference

12 December 2020

Lamotrigine in treatment of 120 children with epilepsy

1 reference

12 December 2020

The phenytoin syndrome

1 reference

12 December 2020

Oxcarbazepine sensitivity treated by desensitisation

1 reference

12 December 2020

Lamotrigine clinical pharmacokinetics

1 reference

12 December 2020

In vitro analysis of idiosyncratic drug reactions

1 reference

12 December 2020

Suppression of carbamazepine-induced skin rash with prednisone

1 reference

12 December 2020

Carbamazepine-induced drug rashes: diagnostic value of patch tests depends on clinico-pathologic presentation

1 reference

12 December 2020

Safety of lamotrigine

1 reference

12 December 2020

Anticonvulsant hypersensitivity syndrome

1 reference

12 December 2020

High incidence of a concentration-dependent skin reaction in children treated with phenytoin

1 reference

12 December 2020

Generalized Pustulation as a Manifestation of the Anticonvulsant Hypersensitivity Syndrome

1 reference

12 December 2020

In vitro analysis of metabolic predisposition to drug hypersensitivity reactions

1 reference

12 December 2020

T cell reactions in patients showing adverse immune reactions to drugs

1 reference

12 December 2020

Patch test diagnosis in carbamazepine erythroderma

1 reference

12 December 2020

Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature

1 reference

12 December 2020

Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine

1 reference

12 December 2020

Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation

1 reference

12 December 2020

Carbamazepine-induced eruption histologically mimicking mycosis fungoides

1 reference

12 December 2020

In-vitro assessment of a hypersensitivity syndrome associated with sorbinil

1 reference

12 December 2020

A nodular cutaneous lymphoproliferative disorder during carbamazepine administration

1 reference

12 December 2020

Acute respiratory failure mediated by reactive drug metabolites

1 reference

12 December 2020

Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature

1 reference

12 December 2020

In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity

1 reference

12 December 2020

Drug-induced mycosis fungoides-like lesions

1 reference

12 December 2020

Phenytoin-induced hypersensitivity reactions

1 reference

12 December 2020

Lymphocyte activation in allergic reactions elicited by small-molecular-weight compounds

1 reference

12 December 2020

Phenytoin hypersensitivity: 38 cases

1 reference

12 December 2020

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

1 reference

12 December 2020

Anticonvulsant toxicity in vitro: possible role of arene oxides

1 reference

12 December 2020

Leucopenia associated with lamotrigine

1 reference

12 December 2020

Mycosis fungoides—like lesions associated with phenytoin and carbamazepine therapy

1 reference

12 December 2020

Serum anticonvulsant concentrations and the risk of drug induced skin eruptions

1 reference

12 December 2020

Anticonvulsant hypersensitivity syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome

1 reference

12 December 2020

Carbamazepine hypersensitivity reaction

1 reference

12 December 2020

Fulminant hepatic failure induced by lamotrigine

1 reference

12 December 2020

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-1996. A seven-year-old boy with fever, lymphadenopathy, hepatosplenomegaly, and prominent eosinophilia

1 reference

12 December 2020

Predisposition to phenytoin hepatotoxicity assessed in vitro

1 reference

12 December 2020

Lamotrigine and toxic epidermal necrolysis

1 reference

12 December 2020

Adverse reactions to carbamazepine managed by desensitisation

1 reference

12 December 2020

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

1 reference

12 December 2020

Fatal toxic epidermal necrolysis related to lamotrigine administration.

1 reference

12 December 2020

Cutaneous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients

1 reference

12 December 2020

Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions

1 reference

12 December 2020

Suppression of carbamazepine-induced rash with prednisone

1 reference

12 December 2020

Epicutaneous test in carbamazepine cutaneous reactions

1 reference

12 December 2020

Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions

1 reference

12 December 2020

Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas

1 reference

12 December 2020

Familial occurrence of hypersensitivity to phenytoin

1 reference

12 December 2020

Antiepileptic drug hypersensitivity syndrome

1 reference

12 December 2020

Phenobarbital hypersensitivity reaction

1 reference

12 December 2020

Patch testing in cutaneous reactions caused by carbamazepine

1 reference

12 December 2020

Cutaneous Reactions in Head-injured Patients Receiving Phenytoin for Seizure Prophylaxis

1 reference

12 December 2020

Plasmapheresis in toxic epidermal necrolysis

1 reference

12 December 2020

Patch tests in drug eruptions

1 reference

12 December 2020

Hypersensitivity to carbamazepine presenting as pseudolymphoma

1 reference

12 December 2020

Erythroderma from carbamazepine

1 reference

12 December 2020

Hepatitis as a manifestation of phenobarbital hypersensitivity

1 reference

12 December 2020

Pseudolymphoma syndrome. A sensitivity to anticonvulsant drugs

1 reference

12 December 2020

Lamotrigine-associated anticonvulsant hypersensitivity syndrome

1 reference

12 December 2020

Adverse reactions to carbamazepine managed by desensitisation.

1 reference

12 December 2020

A pseudolymphomatous reaction in soft tissue associated with phenytoin sodium

1 reference

12 December 2020

Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides

1 reference

12 December 2020

Systemic corticosteroids in the phenytoin hypersensitivity syndrome

1 reference

12 December 2020

Acute hypersensitivity pneumonitis associated with carbamazepine therapy

1 reference

12 December 2020

Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities

1 reference

12 December 2020

Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid

1 reference

12 December 2020

Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations

1 reference

12 December 2020

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study

1 reference

12 December 2020

Prevalence of the epilepsies in children and adolescents.

1 reference

12 December 2020

Diphenylhydantoin--induced hepatic necrosis

1 reference

12 December 2020

Serious dermatologic reactions in children.

1 reference

12 December 2020

Carbamazepine-induced pseudolymphoma and immune dysregulation

1 reference

12 December 2020

Lamotrigine for the treatment of epilepsy in childhood

1 reference

12 December 2020

Diphenylhydantoin-induced hepatitis

1 reference

12 December 2020

Suspected lamotrigine-induced toxic epidermal necrolysis

1 reference

12 December 2020

Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy"

1 reference

12 December 2020

Anticonvulsant-induced liver damage

1 reference

12 December 2020

Convulsive disorders: toxicity of anticonvulsants

1 reference

12 December 2020

Sodium valproate acutely inhibits lamotrigine metabolism

1 reference

12 December 2020

Carbamazepine-induced skin rash in children with epilepsy

1 reference

12 December 2020

Phenytoin-like hypersensitivity associated with lamotrigine.

1 reference

12 December 2020

Pseudo-lymphoma associated with carbamazepine

1 reference

12 December 2020

Carbamazepine-induced anticonvulsant hypersensitivity syndrome--pathogenic and diagnostic considerations

1 reference

12 December 2020

Severe adverse cutaneous reactions to drugs

1 reference

12 December 2020

10.2165/00002018-199921060-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference